Nest, Bulk Filling Solutions Robotics, Isolators Showcased at Achema 2022

Source: Press release Ahlam Rais |

Related Vendors

At the trade show, Steriline is showcasing a Robotic Vial Filling and Capping Machine under isolator (RVFCM50) along with a Robotic Nest Filling Machine under double-wall isolator (RNFM5) which are key features of its nest and bulk filling solutions.

Steriline is presenting a Robotic Vial Filling and Capping Machine under isolator (RVFCM50) and a Robotic Nest Filling Machine under double-wall isolator (RNFM5) at this year’s Achema.
Steriline is presenting a Robotic Vial Filling and Capping Machine under isolator (RVFCM50) and a Robotic Nest Filling Machine under double-wall isolator (RNFM5) at this year’s Achema.
(Source: Steriline)

Steriline is presenting a Robotic Vial Filling and Capping Machine under isolator (RVFCM50) and a Robotic Nest Filling Machine under double-wall isolator (RNFM5) at this year’s Achema. The RVFCM50 can process up to 2,400 pcs/h. Once vials are washed and depyrogenated, the first of three robotic arms grasps two vials at a time and places them under the filling heads, which are linked to two peristaltic pumps that potentially allow infinite capacity filling. This step happens directly on two weighing cells, so that the filling volume can be checked in real-time during filling operations and the recipe parameters can be met.

Once they have been properly filled, the vials are moved to the second robotic arm for the stoppering process and then to the third robotic arm for capping. Whenever the check sensors detect any non-conformity during filling, stoppering or capping, the process can be repeated to guarantee the conformity needed according to the company’s ‘robotics zero-loss philosophy’, states the company. The main processes of primary packaging are three: filling, stoppering and capping. In traditional solutions, they may fail, leading to non-compliant products being rejected. Steriline’s ‘Zero-loss philosophy’ aims in this case to avoid waste. Sensors combined with robotics can detect any problem and ensure the process is repeated until the requested standards are achieved, adds the firm.

The machine was designed to manage highly potent drugs that are potentially dangerous for people and, for this reason, it is equipped with an isolator that ensures the sterility of the processed vials and protects the operator at the same time. According to the company, this new robotic line will allow the customer, a Contract Development and Manufacturing Organization (CDMO), to:

  • further differentiate its offer, processing a wide range of packaging solutions;
  • add toxic products to its own portfolio.

The RNFM5 under double-wall isolator can process every container that comes in nested form, including syringes, vials and cartridges. In the filling area, a vertical manipulator, equipped with suction cups, removes the nest from the tub, allowing the first robotic arm to pick up the nest and place it under the filling needles and stoppering heads.

A second robotic arm picks up containers and performs the statistical weight checking process, with the help of five high-precision weighing cells located on the machine baseplate. The glass containers are then moved under five dosing heads and simultaneously stoppered. Seals are used on syringes and cartridges, while vials are stoppered with the all-in-one closure system developed by Araymondlife (which integrates plastic push-fit caps).

In addition to the weight-checking sensors, which ensure the right fill quantity, the machine is also equipped with Steriline’s smart bung system, which can detect the conformity of the stoppering process. In this case, Steriline’s smart bung system relies on pressure sensors to monitor the stoppering process. If anomalies are detected, the process can be repeated to ensure containers are hermetically sealed as requested.

The RNFM5 answers to the client’s need to introduce a new production line to start the commercialization of a new biotech drug. Its output is up to 10,000 pieces/h with a double-wall isolator solution that guarantees sterility throughout the entire process and maximum safety for operators. This solution perfectly satisfies all the requirements for the production of extremely sensitive drugs, such as biosimilars and monoclonal antibodies, in addition to biotech drugs, concludes the firm.

(ID:48547802)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent